{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":300,"width":600,"title":"Hemophilia B and Telemedicine with Zebra For Care!","description":"Could new research change the way hemophilia B carriers are cared for during pregnancy? On this episode of BloodStream, Patrick and Amy explore emerging research that challenges long-held assumptions about factor IX levels during pregnancy and what it could mean for patients and providers. Nathan Mermilliod shares his experience living with hemophilia B, and Dr. Steven Fein discusses the evolving landscape of telemedicine in partnership with Zebra for Care.  From new discoveries to lived experiences, this episode highlights the stories and science moving the bleeding disorders community forward. &amp;nbsp; Show Notes:  Contrary to current guidance, antenatal factor IX levels increase in female carriers of hemophilia B  Hope for Hemophilia&amp;nbsp; Zebra Care &amp;nbsp; Presenting Sponsor: Takeda, visit bleedingdisorders.com to learn more.    Subscribe: The BloodStream Podcast &amp;nbsp; Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook&amp;nbsp; BloodStream on X\/Twitter&amp;nbsp; BloodStream on Instagram BloodStream on LinkedIn BloodStream on TikTok &amp;nbsp; &amp;nbsp; ","author_name":"BloodStream","author_url":"http:\/\/BloodStreamPod.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/42198375\/height\/300\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"300\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/204412735"}